Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Michael A Conley"'
Publikováno v:
Journal of Interprofessional Care. 37:320-324
Autor:
Macayla A. Bartucca, Thomas M. Matta, Jenny Mullakary, Brandon Dionne, Michael P. Conley, Sarah Visintainer, Carla Bouwmeester, Mitchell Tucci, Debra J. Reid
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:689-696
Publikováno v:
Archives of Clinical Neuropsychology. 37:1379-1379
Objective: The Texas Postconcussion Symptom Inventory (TPSI) is a novel, 66-item, self-report instrument with empirically-derived indices that provides a summed total score to assess recovery following concussion. This study evaluated convergent vali
Autor:
Jessica H Helphrey, Julia R Livingstone, Anthony J Longoria, Michael A Conley, Jennifer D Sawyer, Anne R Carlew, Christian LoBue, Munro M Cullum
Publikováno v:
Archives of Clinical Neuropsychology. 36:1210-1210
Objective Despite the growing interest and literature supporting the validity and reliability of teleneuropsychology during the COVID-19 pandemic, little research exists on the reliability of the Oral Trail Making Test (OTMT) administered via videoco
Autor:
Michael A. Conley, Anne R Carlew, Munro Cullum, Saranya Patel, Jeffrey Schaffert, Laura H. Lacritz, Heidi Rossetti, David A. Denney
Publikováno v:
Archives of Clinical Neuropsychology. 36:1252-1252
Objective Various methods are used to derive normative data for neuropsychological assessment measures. The National Alzheimer’s Coordinating Center (NACC) regression norms (2011) are frequently used within Alzheimer’s Disease Research Centers, y
Autor:
Tayla N, Rose, Michelle L, Jacobs, Debra J, Reid, Carla J, Bouwmeester, Michael P, Conley, Borna, Fatehi, Thomas M, Matta, Judith T, Barr
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 60(1)
Glucagon-like peptide-1 (GLP-1) receptor agonists are preferred injectable therapies for type 2 diabetes, but their high cost is an area of concern. This study evaluated monthly glucose-lowering medication cost and clinical impact after initiating a
Autor:
Michelle Jacobs, Borna Fatehi, Thomas M. Matta, Tayla N. Rose, Carla Bouwmeester, Michael P. Conley, Debra J. Reid, Judith T. Barr
Publikováno v:
Diabetes. 68
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are preferred injectable therapies for type 2 diabetes, but it is uncertain if advantages justify higher medication cost. This real-world, retrospective cohort study at eight ambulatory care sites
To the Editor: Mr. Bowar and Dr. McCarthy have raised several important aspects of our study as it relates to the wider educational system and we thank them for their perspective and interest in our article. As was noted in the original study and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f55936b41fd907f1ffa5af4aee7741
https://europepmc.org/articles/PMC6498194/
https://europepmc.org/articles/PMC6498194/
Autor:
Michael P. Conley, Kelsey B Sheehan, Jessica M Ryan, Debra J. Reid, Carla Bouwmeester, Stacy L Longo
Publikováno v:
Pharmacy Practice
Pharmacy Practice, Vol 17, Iss 3, p 1499 (2019)
Pharmacy Practice (Granada), Volume: 17, Issue: 3, Article number: 1499, Published: 25 NOV 2019
Pharmacy Practice (Granada) v.17 n.3 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice, Vol 17, Iss 3, p 1499 (2019)
Pharmacy Practice (Granada), Volume: 17, Issue: 3, Article number: 1499, Published: 25 NOV 2019
Pharmacy Practice (Granada) v.17 n.3 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Background: Previous studies linked metformin use to vitamin B12 deficiency and demonstrated that the prevalence of vitamin B12 monitoring remains low. Objective: This study aimed to assess the occurrence of monitoring vitamin B12 levels in a diverse
Autor:
Tayla N. Rose, Michael P. Conley, Michelle Jacobs, Judith T. Barr, Carla Bouwmeester, Debra J. Reid, Borna Fatehi, Thomas M. Matta
Publikováno v:
Journal of the American Pharmacists Association. 60:31-38.e1
Objective Glucagon-like peptide-1 (GLP-1) receptor agonists are preferred injectable therapies for type 2 diabetes, but their high cost is an area of concern. This study evaluated monthly glucose-lowering medication cost and clinical impact after ini